Showing results (71-80 of 140) with videos related to
Sort By:
Pageof 14
Scientific Reports|April 21, 2022
Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, JapanMasashi Fujita, Kazumichi Abe, Hidekatsu Kuroda, et al.Drugs - Real World Outcomes|October 9, 2024
Early Clinical Outcomes of Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma: A Real-World Comparison with First-Line or Later-Line TreatmentYudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, et al.Liver Cancer|October 9, 2025
Primary Analysis of a Phase II Study of Atezolizumab plus Bevacizumab for TACE-Unsuitable Patients with Tumor Burden beyond Up-To-Seven Criteria in Intermediate-Stage Hepatocellular Carcinoma: REPLACEMENT StudyMasatoshi Kudo, Kazuomi Ueshima, Kaoru Tsuchiya, et al.Radiology|October 3, 2023
Multivariable Quantitative US Parameters for Assessing Hepatic SteatosisHidekatsu Kuroda, Takuma Oguri, Naohisa Kamiyama, et al.Liver Cancer|August 18, 2022
Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential TherapyHidekatsu Kuroda, Takayoshi Oikawa, Masashi Ninomiya, et al.Journal of Gastroenterology|October 29, 2024
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varicesHidekatsu Kuroda, Tamami Abe, Naohisa Kamiyama, et al.Journal of Viral Hepatitis|March 7, 2025
Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide AnaloguesJun Inoue, Shinichiro Minami, Kazumichi Abe, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2025
Atezolizumab Plus Bevacizumab for TACE-Unsuitable Intermediate-Stage HCC Beyond Up-To-7 Criteria: Final Analysis of REPLACEMENTKazuomi Ueshima, Kaoru Tsuchiya, Tatsuya Yamashita, et al.Scientific Reports|February 6, 2025
Impact of shear wave elastography and attenuation imaging for predicting life-threatening event in patients with metabolic dysfunction-associated steatotic liver diseaseYudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 9, 2026
Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral TherapyTakanori Suzuki, Kentaro Matsuura, Yuki Tahata, et al.Pageof 14